Sinovac's COVID-19 vaccine followed by a Pfizer-BioNTech shot showed a lower immune response against the Omicron variant compared with other strains. The study, which has not been peer-reviewed yet, was conducted by researchers from Yale University, the Dominican Republic's Ministry of Health and other institutions.

Antibody levels against Omicron were 6.3-fold lower when compared with the ancestral variant. Two-dose Sinovac vaccine alone did not show any detectable neutralization. A study from Hong Kong last week said that even three doses of the Sinovacs vaccine did not produce enough antibody response.

Sinovac's CoronaVac and state-owned Sinopharm's BBIBP-CorV vaccine are the two most-used vaccines in China. Hong Kong has been using the Sinovac and Pfizer-BioNTech vaccines. read more at:
Posted by
Tap to Copy the Short Url to This Post: 
One-Stop Business News backed by Mark Cuban. Free to Use →